Trinity Biotech plc (TRIB)

Trinity Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	24	16	21	30	80	25
Market Cap Growth	-56.60%	-21.00%	-30.77%	-62.47%	220.55%	-54.87%
Enterprise Value	104	80	86	103	154	111
PE Ratio	0.78	-0.68	-0.50	34.16	-12.47	-0.86
PS Ratio	0.43	0.29	0.33	0.37	0.78	0.28
PB Ratio	-0.68	-0.68	-9.51	-93.70	-35.89	5.27
P/FCF Ratio	-	-1.12	-3.01	10.17	5.50	-3.86
P/OCF Ratio	-	-1.38	-22.79	2.57	3.23	4.59
EV/Sales Ratio	1.84	1.41	1.38	1.27	1.51	1.22
EV/EBITDA Ratio	-	-7.12	-6.11	9.70	54.52	-6.00
EV/EBIT Ratio	-7.49	-6.15	-5.24	13.08	-598.23	-4.74
EV/FCF Ratio	-	-5.50	-12.54	35.10	10.62	-17.19
Debt / Equity Ratio	-3.75	-2.82	-33.18	-310.84	-45.71	21.68
Debt / EBITDA Ratio	-	-6.00	-5.11	9.33	35.97	-5.54
Debt / FCF Ratio	-	-4.63	-10.49	33.75	7.01	-15.87
Quick Ratio	1.01	1.17	1.29	0.42	1.85	1.92
Current Ratio	2.02	2.60	2.69	0.72	3.08	3.67
Asset Turnover	0.80	0.79	0.62	0.65	0.78	0.56
Interest Coverage	-1.45	-1.18	-0.67	1.11	-0.04	-3.55
Return on Equity (ROE)	113.80%	161.60%	-1172.40%	-2651.50%	-520.60%	-91.20%
Return on Assets (ROA)	-30.20%	-33.60%	-40.70%	0.70%	-4.90%	-17.80%
Return on Capital (ROIC)	-41.68%	-62.20%	-27.63%	4.35%	0.08%	-22.56%
Earnings Yield	-88.14%	-146.92%	-198.18%	2.93%	-8.02%	-116.38%
FCF Yield	-89.14%	-33.27%	9.83%	18.17%	-25.91%
Buyback Yield / Dilution	-82.32%	-	-	13.06%	-
Total Shareholder Return	-82.32%	-	-	13.06%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).